Non-invasive quantification of hepatic fat content in healthy dogs by using proton magnetic resonance spectroscopy and dual gradient echo magnetic resonance imaging - PubMed (original) (raw)

Non-invasive quantification of hepatic fat content in healthy dogs by using proton magnetic resonance spectroscopy and dual gradient echo magnetic resonance imaging

Francesca Del Chicca et al. J Vet Sci. 2018.

Abstract

The objective of the present study was to describe two non-invasive methods for fat quantification in normal canine liver by using magnetic resonance imaging (MRI) and spectroscopy. Eleven adult beagle dogs were anesthetized and underwent magnetic resonance examination of the cranial abdomen by performing morphologic, modified Dixon (mDixon) dual gradient echo sequence, and proton magnetic resonance spectroscopy (1H MRS) imaging. In addition, ultrasonographic liver examination was performed, fine-needle liver aspirates and liver biopsies were obtained, and hepatic triglyceride content was assayed. Ultrasonographic, cytologic, and histologic examination results were unremarkable in all cases. The median hepatic fat fraction calculated was 2.1% (range, 1.3%-5.5%) using mDixon, 0.3% (range, 0.1%-1.0%) using 1H MRS, and 1.6% (range 1.0%-2.5%) based on triglyceride content. The hepatic fat fractions calculated using mDixon and 1H MRS imaging were highly correlated to that based on triglyceride content. A weak correlation between mDixon and 1H MRS imaging was detected. The results show that hepatic fat content can be estimated using non-invasive techniques (mDixon or 1H MRS) in healthy dogs. Further studies are warranted to evaluate the use of these techniques in dogs with varying hepatic fat content and different hepatic disorders.

Keywords: canine; hepatic triglyceride; liver; magnetic resonance imaging; proton magnetic resonance spectroscopy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declare no conflicts of interest.

Figures

References

    1. Borra RJ, Salo S, Dean K, Lautamäki R, Nuutila P, Komu M, Parkkola R. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology. 2009;250:130–136. - PubMed
    1. Chandarana H, Taouli B. Diffusion and perfusion imaging of the liver. Eur J Radiol. 2010;76:348–358. - PubMed
    1. Clark MH, Larsen R, Lu W, Hoenig M. Investigation of 1H MRS for quantification of hepatic triglyceride in lean and obese cats. Res Vet Sci. 2013;95:678–680. - PubMed
    1. Cullen JM, van den Ingh TSGAM, Van Winkle T, Charles JA, Desmet VJ. WSAVA Liver Standardization Group, editors. Morphological classification of parenchymal disorders of the canine and feline liver: 1. Normal histology, reversible hepatocytic injury and hepatic amyloidosis. In: Rothuizen J, Bunch SE, Charles JA, Cullen JM, Desmet VJ, Szatmári V, Twedt DC, van den Ingh TSGAM, Van Winkle T, Washabau RJ, editors. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease. Philadelphia: Elsevier; 2006. pp. 77–83.
    1. Drost WT, Henry GA, Meinkoth JH, Woods JP, Lehenbauer TW. Quantification of hepatic and renal cortical echogenicity in clinically normal cats. Am J Vet Res. 2000;61:1016–1020. - PubMed

MeSH terms

LinkOut - more resources